Glaucoma is one of the leading causes of permanent blindness in the world, affecting more than two million Americans, and more than one hundred million people worldwide. It is a disease of the optic ...
Medication, laser, and surgery are all methods of treating glaucoma according to Jonathan Eisengart, MD. Jonathan Eisengart, MD, an ophthalmologist at Cleveland Clinic, explained how different ...
A review of selective laser trabeculoplasty in glaucoma management, and when it is appropriate to consider as a treatment option. Neil Minkoff, MD: As we move into different types of therapy, laser ...
Please provide your email address to receive an email when new articles are posted on . Femtosecond laser technology for glaucoma treatment demonstrated safety at 2 years. The risk for hyphema ...
ViaLase, a medical technology startup developing a new femtosecond laser treatment for glaucoma, has closed its series C funding round with $40 million in additional finance. Based in Alisa Viejo, ...
ALISO VIEJO, Calif., December 03, 2025--(BUSINESS WIRE)--ViaLase, Inc., a clinical-stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced that ...
Please provide your email address to receive an email when new articles are posted on . In refractive and cataract surgery, femtosecond lasers have increased precision and reduced complications. They ...
In Bihar, awareness about glaucoma is gradually increasing, and many eye hospitals now provide advanced treatment solutions based on the stage and type of the disease.
LOS ANGELES & MUNICH--(BUSINESS WIRE)--ELT Sight, Inc. today announced that the American Medical Association (AMA) approved two new Category III Current Procedural Terminology (CPT®) codes to report ...
Experts explain whether Lasik or lens implants affect your risk, and how a hair strand-like microshunt could reduce reliance on lifelong eye drops for patients.
AI could revolutionise glaucoma detection. Here’s 6 things everyone should know - Age and family history are significant risk ...